Pangaea Oncology, S.A. (BME:PANG)
Spain flag Spain · Delayed Price · Currency is EUR
1.470
0.00 (0.00%)
Nov 13, 2026, 4:00 PM CET

Pangaea Oncology Income Statement

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1514.5214.2784.374.6
Revenue Growth
0.45%1.78%78.41%83.12%-5.11%12.29%
Cost of Revenue
2.832.582.742.42.731.65
Gross Profit
12.1711.9411.535.61.632.95
Selling, General & Admin
15.8915.2514.049.355.354.41
Other Operating Expenses
-2.4-2.2-2.88-2.12-2.26-1.81
Operating Expenses
16.3515.8313.729.054.333.59
Operating Income
-4.18-3.89-2.19-3.44-2.7-0.64
Interest Expense
-0.29-0.3-0.3-0.13-0.19-0.25
Interest & Investment Income
000.020.120.020
Earnings From Equity Investments
----0.06-0.16-0.19
Currency Exchange Gain (Loss)
-0.020.01-0.01-0.010-0.01
Other Non Operating Income (Expenses)
0.120.150.430.130.140.09
EBT Excluding Unusual Items
-4.37-4.02-2.06-3.39-2.88-1.01
Impairment of Goodwill
----0.51--
Gain (Loss) on Sale of Investments
---0.390.04-0.09
Asset Writedown
--0.36---
Pretax Income
-4.37-4.02-1.69-3.51-2.84-1.1
Income Tax Expense
1.07-0.46-0.51.29-0.11-0.46
Earnings From Continuing Operations
-5.44-3.57-1.2-4.79-2.72-0.64
Earnings From Discontinued Operations
---0.07---
Net Income to Company
-5.44-3.57-1.27-4.79-2.72-0.64
Minority Interest in Earnings
0.1-0.030.10.140.01-
Net Income
-5.34-3.6-1.17-4.66-2.71-0.64
Net Income to Common
-5.34-3.6-1.17-4.66-2.71-0.64
Net Income Growth
------
Shares Outstanding (Basic)
3636-303023
Shares Outstanding (Diluted)
3636-303023
Shares Change
5.30%---0.98%35.11%20.34%
EPS (Basic)
-0.15-0.10--0.15-0.09-0.03
EPS (Diluted)
-0.15-0.10--0.15-0.09-0.03
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-3.59-2.97-5.05-2.65-3.7-2.53
Free Cash Flow Per Share
-0.10-0.08--0.09-0.12-0.11
Gross Margin
81.13%82.21%80.81%70.03%37.43%64.09%
Operating Margin
-27.87%-26.79%-15.33%-43.05%-61.74%-13.93%
Profit Margin
-35.60%-24.76%-8.18%-58.22%-62.09%-13.94%
Free Cash Flow Margin
-23.96%-20.44%-35.38%-33.18%-84.61%-54.89%
EBITDA
-3.64-2.6-0.85-2.69-2.31-0.27
EBITDA Margin
-24.29%-17.92%-5.92%-33.69%-52.91%-5.85%
D&A For EBITDA
0.541.291.340.750.390.37
EBIT
-4.18-3.89-2.19-3.44-2.7-0.64
EBIT Margin
-27.87%-26.79%-15.33%-43.05%-61.74%-13.93%
Revenue as Reported
0.47--84.37-
Advertising Expenses
-0.110.10.180.070.03